Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
BMC Nuclear Medicine · 2007
DOI: 10.1186/1471-2385-7-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Nuclear Medicine, 2007. Verfasst von Eric Turcotte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Division of Nuclear Medicine, University of Washington, Seattle, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
18 F-FLT is a novel PET radiotracer which has demonstrated a strong potential utility for imaging cellular proliferation in human tumors in vivo. To facilitate future regulatory approval of 18 F-FLT for clinical use, we wished to demonstrate the safety of radiotracer doses of 18 F-FLT administered to human subjects, by: 1) performing an evaluation of the toxicity of 18 F-FLT administered in radiotracer amounts for PET imaging, 2) comparing a radiotracer dose of FLT to clinical trial doses of FLT.
Methods
Twenty patients gave consent to a 18 F-FLT injection, subsequent PET imaging, and blood draws. For each patient, blood samples were collected at multiple times before and after 18 F-FLT PET. These samples were assayed for a comprehensive metabolic panel, total bilirubin, complete blood and platelet counts. 18 F-FLT doses of 2.59 MBq/Kg with a maximal dose of 185 MBq (5 mCi) were used. Blood time-activity curves were generated for each patient from dynamic PET data, providing a measure of the area under the FLT concentration curve for 12 hours (AUC 12 ).
Results
No side effects were reported. Only albumin, red blood cell count, hematocrit and hemoglobin showed a statistically significant decrease over time. These changes are attributed to IV hydration during PET imaging and to subsequent blood loss at surgery. The AUC 12 values estimated from imaging data are not significantly different from those found from serial measures of FLT blood concentrations ( p = 0.66). The blood samples-derived AUC 12 values range from 0.232 ng*h/mL to 1.339 ng*h/mL with a mean of 0.802 ± 0.303 ng*h/mL. This corresponds to 0.46% to 2.68% of the lowest and least toxic clinical trial AUC 12 of 50 ng*h/mL reported by Flexner et al (1994). This single injection also corresponds to a nearly 3,000-fold lower cumulative dose than in Flexner's twice daily trial.
Conclusion
This study shows no evidence of toxicity or complications attributable to 18 F-FLT injected intravenously.
Autor:innen und Institutionen
- Department of Radiology, Division of Nuclear Medicine, University of Washington, Seattle, USA.
- Department of Laboratory Medicine, University of Washington, Seattle, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Turcotte, E., Wiens, L. W., Grierson, J. R., Peterson, L. M., Wener, M. H., & Vesselle, H. (2007). Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses. BMC Nuclear Medicine. https://doi.org/10.1186/1471-2385-7-3
Vancouver
Turcotte E, Wiens LW, Grierson JR, Peterson LM, Wener MH, Vesselle H. Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses. BMC Nuclear Medicine. 2007. doi:10.1186/1471-2385-7-3
BibTeX
@article{Turcotte2007,
author = {Turcotte, Eric and Wiens, Linda W and Grierson, John R and Peterson, Lanell M and Wener, Mark H and Vesselle, Hubert},
title = {Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses},
journal = {BMC Nuclear Medicine},
year = {2007},
doi = {10.1186/1471-2385-7-3}
}
EUVIMED